NCT07550764Completed
Effect of Infrared-Assisted Intravenous Catheterization on Patient Comfort in Lung Cancer Patients
Effect of Infrared-Assisted Intravenous Catheterization on Patient Comfort in Lung Cancer Patients: A Mixed-Methods Study
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
This study evaluated the effect of near-infrared (NIR) vein visualization-assisted peripheral intravenous catheterization on procedure-specific patient comfort and procedural pain in adults with lung cancer receiving outpatient chemotherapy. Patients receiving chemotherapy often develop progressive venous damage, which can make peripheral intravenous catheterization difficult. Failed attempts may increase pain and discomfort. The study used an explanatory sequential mixed-methods design (QUAN→qual). In the quantitative phase, 160 patients were randomized 1:1 to NIR-assisted catheterization or to standard catheterization based on visual inspection and palpation. In the qualitative phase, semi-structured individual interviews were conducted with 11 patients from the intervention group to explore their experiences with the NIR device. The study was conducted at the Outpatient Chemotherapy Unit of Ataturk University Research Hospital, Erzurum, Turkey, as part of a doctoral thesis in Fundamentals of Nursing.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 160 (actual)
- First submitted
- 12 Apr 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- Ataturk University
- Diseases
- Lung cancer
- NCT number
- NCT07550764
What you commit to
- Study type: Interventional
- Participants enrolled: 160
- From 1 Apr 2026 to the primary completion date, 31 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Anatomical anomaly, amputation, post-mastectomy lymphedema or arteriovenous fistula in both upper extremities
- Active local infection, dermatitis or impaired skin integrity at the planned catheterization site
- Need for an off-protocol intervention (decision for central access after failure at the third attempt)
- Development of an acute clinical condition preventing completion of data collection
Other
- Situations requiring emergency or life-saving catheterization
- Presence of a central venous catheter (port, PICC or tunneled catheter)
- Altered consciousness or disorientation
- Mediastinal, supraclavicular or infraclavicular mass/lymphadenopathy that may affect upper extremity venous return
- Withdrawal Criteria:
- Withdrawal of consent at any stage
Who the study is looking for
- Aged 18 years or older
- Histopathologically confirmed lung cancer (small cell or non-small cell)
- Receiving active systemic chemotherapy (at least one cycle completed)
- Indication for a peripheral intravenous catheter for chemotherapy administration
- Able to speak and understand Turkish sufficiently to communicate
- Read and signed the informed consent form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ataturk University Research Hospital Coordinator of this site? Confirm its status | Erzurum | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.